×

Novartis will remain under pressure: pro

3:30 AM ET Wed, 17 July 2013

Andrew Weiss, head of pharma and biotech research at Vontobel, , talks about Novartis' quarterly results and outlook and says the company will remain under pressure for the next few quarters.